Maglasang, Rex Harold R.
HRN: 21-36-24 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2025
CEFTRIAXONE 1G (VIAL)
04/13/2025
04/20/2025
IV
2G
OD
For Herniorrhaphy
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes